Showing 137 news articles about Injectable & long-acting HIV treatment

Filters Content type: Editors' picks Topic: Injectable & long-acting HIV treatment

Research into injectable medications and other innovative forms of HIV treatment. It is hoped that they may only need to be taken every few weeks or months, rather than daily.

 

PrEP science

Long-acting Injectable Antiretrovirals for PrEP: Will the tail wag the drug?

Editor's pick
AVAC
9 June 2017
People with limited treatment options

People With Multidrug-Resistant HIV Can Now Start Treatment on the Experimental Drug Ibalizumab

Editor's pick
TheBody.com
15 December 2016
New & experimental HIV treatments

Charlie Sheen Achieves Undetectable Viral Load With Weekly Injectable HIV Treatment

Editor's pick
The Body
8 December 2016
New & experimental HIV treatments

China to approve 1st long-acting injection to treat HIV/AIDS

Editor's pick
Global Times
25 November 2016
New & experimental HIV treatments

ViiV Healthcare launches phase III programme to evaluate a long-acting, injectable HIV treatment regimen

Editor's pick
ViiV press release
21 November 2016
PrEP

More Surprises From ÉCLAIR: Cabotegravir's 'Long Tail'

Editor's pick
Medscape (requires free registration)
26 October 2016
New & experimental HIV treatments

The HIV Treatment Pipeline

Editor's pick
Poz
28 June 2016
New & experimental HIV treatments

Frontier Biotech's Long-acting HIV-1 Fusion Inhibitor Albuvirtide Meets 48-Week Primary Objective: Interim Results of a Phase 3 Trial

Editor's pick
Frontier Biotech press release
7 June 2016
PrEP

What is a drug “tail,” and what does it have to do with long-acting PrEP?

Editor's pick
BETA blog
25 February 2016
New & experimental HIV treatments

IV and Injectable HIV Treatments Are Much Discussed -- But Won't Be Here Anytime Soon

Editor's pick
TheBody Pro
21 January 2016
New & experimental HIV treatments

Janssen, ViiV Healthcare Formalize Injectable Rilpivirine + Cabotegravir Phase 3 as HIV Treatment

Editor's pick
Street Insider
8 January 2016
Injectable & long-acting HIV treatment

Long-acting injectable HIV treatment shows promise in early study results

Editor's pick
Science Speaks
4 November 2015
New & experimental HIV treatments

Drug-level study shows feasibility of long-acting integrase inhibitor cabotegravir

Editor's pick
HIVand hepatitis.com
10 September 2014
Injectable & long-acting HIV treatment

Long-acting HIV drugs advanced to overcome adherence challenge

Editor's pick
Nature Medicine
8 April 2014
PrEP

Long-Acting HIV Antiretrovirals May Be Revolutionary. But Will They Be Worth It?

Editor's pick
The Body Pro
6 October 2013
New & experimental HIV treatments

Good safety profile with long-acting integrase inhibitor, GSK744

Editor's pick
NATAP
19 September 2013
New & experimental HIV treatments

Ibalizumab Study Casts a Ray of Hope for HIV-Infected People With Extensive Drug Resistance

Editor's pick
The Body
21 September 2011